Table 1 Baseline Characteristics of long-term versus short-term responders
HER2-long Responders (N = 24) | HER2-short Responders (N = 62) | |
|---|---|---|
Age (med, IQR) | 57 years (48–67) | 52 years (32–60) |
Visceral disease (yes) | 46% | 76% |
ER-Status (pos) | 59% | 60% |
PgR-Status (pos) | 48% | 41% |
FISH (med. Ratio, IQR) | 4.8 (4.1–5.3) | 4.7 (2.5–5.3) |
ALP U/l (med, IQR) | 74 (62–118) | 103 (65–193) |
Hb g/l (med, IQR) | 130 (122–137) | 134 (125–140) |
WBC G/l (med, IQR) | 5.8 (5.1–6.7) | 6.8 (6.0–8.5) |
Adjuvant endocrine treatment (yes) | 33% | 48% |